[Clinical uses of flow cytometry in hematological oncology].
In the last decades, the classification of schemes of haematological malignancies have undergone considerable changes both in terms of modifications of previous concepts and of methodological approaches, in parallel with the acquisition of new information on the physiopathological and functional pattern of haemic cells and of their precursors both at the lymph node and bone marrow level. The cyto-morphological aspects of haemic were better defined and integrated by the application of cyto- and histochemical methods, which were subsequently supplemented by bioenzymatic and cytogenetic techniques, then by immunophenotypical studies and finally by biomolecular investigations. Through the use of monoclonal antibodies and the introduction both in research and routine diagnostic practice of multiparameter analysis techniques, it is now possible to correlate several cellular parameters, to identify clonality of malignant cells as well as their lineage assignment and maturation stage. Flow cytometry has become an important, rapid and objective method for the diagnosis of haematological neoplasias. In the present survey we have illustrated the different expression of surface, cytoplasmic and nuclear antigens in haematological malignancies, their correlation with the clinical course of the disease and their diagnostic and prognostic significance.
D'Ostilio
A
A
Dipartimento di Medicina Interna e Sanità Pubblica, Università, L'Aquila.
Ginaldi
L
L
Marini
L
L
Di Gennaro
A
A
De Martinis
M
M
Quaglino
D
D
D000911:Antibodies, Monoclonal; D015415:Biomarkers; D005434:Flow Cytometry; D019337:Hematologic Neoplasms / Q000175:diagnosis* / Q000276:immunology; D006801:Humans; D007938:Leukemia / Q000175:diagnosis / Q000276:immunology; D008223:Lymphoma / Q000175:diagnosis / Q000276:immunology; D008232:Lymphoproliferative Disorders / Q000175:diagnosis / Q000276:immunology; D011379:Prognosis
D000911:Antibodies, Monoclonal; D015415:Biomarkers